In advanced non-small cell lung cancer, the ERCC1 expression has a significant prognostic value and its high level is associated with a longer survival in patients who do not receive chemotherapy after a complete resection [31,32]. The gene discussed is ERCC1; the disease is non-small cell lung carcinoma.